{"id":38415,"date":"2024-09-11T10:44:59","date_gmt":"2024-09-11T10:44:59","guid":{"rendered":"https:\/\/fibrosisquistica.org\/?p=38415"},"modified":"2024-09-11T10:45:02","modified_gmt":"2024-09-11T10:45:02","slug":"boletin-informativo-sobre-el-proyecto-de-investigacion-hit-cf-europe-septiembre-2024","status":"publish","type":"post","link":"https:\/\/fibrosisquistica.org\/en\/boletin-informativo-sobre-el-proyecto-de-investigacion-hit-cf-europe-septiembre-2024\/","title":{"rendered":"Bolet\u00edn informativo sobre el proyecto de investigaci\u00f3n HIT-CF Europe \u2013 Septiembre 2024"},"content":{"rendered":"<p><strong>La Asociaci\u00f3n Europea de Fibrosis Qu\u00edstica (CF Europe) ha publicado su bolet\u00edn informativo de septiembre 2024 sobre la evoluci\u00f3n del proyecto de investigaci\u00f3n HIT-CF Europe.<\/strong><\/p>\n\n\n\n<p>Este proyecto tiene como objetivo evaluar la eficacia y seguridad de diferentes f\u00e1rmacos (moduladores CFTR y otros) en personas con FQ y mutaciones raras basadas en la respuesta de organoides intestinales.<\/p>\n\n\n\n<p>A continuaci\u00f3n, os dejamos el bolet\u00edn traducido al espa\u00f1ol y en formato PDF para descargar:<\/p>\n\n\n\n<p class=\"has-text-align-center\"><a href=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp.pdf\">Bolet\u00edn HIT-CF septiembre 2024 espa\u00f1ol<\/a><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-1.jpg\"><img loading=\"lazy\" decoding=\"async\" width=\"709\" height=\"1024\" src=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-1-709x1024.jpg\" alt=\"\" class=\"wp-image-38417\" title=\"\" srcset=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-1-709x1024.jpg 709w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-1-600x867.jpg 600w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-1-208x300.jpg 208w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-1-8x12.jpg 8w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-1.jpg 720w\" sizes=\"auto, (max-width: 709px) 100vw, 709px\" \/><\/a><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-2.jpg\"><img loading=\"lazy\" decoding=\"async\" width=\"709\" height=\"1024\" src=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-2-709x1024.jpg\" alt=\"\" class=\"wp-image-38418\" title=\"\" srcset=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-2-709x1024.jpg 709w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-2-600x867.jpg 600w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-2-208x300.jpg 208w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-2-8x12.jpg 8w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2024\/09\/HIT-CF-Newsletter-September-2024_esp-2.jpg 720w\" sizes=\"auto, (max-width: 709px) 100vw, 709px\" \/><\/a><\/figure>\n\n\n\n<p><strong>M\u00e1s informaci\u00f3n en la web\u00a0<\/strong><a href=\"https:\/\/www.hitcf.org\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\"><strong>www.hitcf.org<\/strong><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>La Asociaci\u00f3n Europea de Fibrosis&#8230;<\/p>","protected":false},"author":22,"featured_media":38421,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[64],"tags":[],"class_list":{"0":"post-38415","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investigacion"},"acf":[],"_links":{"self":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts\/38415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/comments?post=38415"}],"version-history":[{"count":1,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts\/38415\/revisions"}],"predecessor-version":[{"id":38422,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts\/38415\/revisions\/38422"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/media\/38421"}],"wp:attachment":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/media?parent=38415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/categories?post=38415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/tags?post=38415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}